BOSTON, March 28, 2025 (GLOBE NEWSWIRE) -- HilleVax, Inc. (Nasdaq: HLVX), a clinical-stage biopharmaceutical company focused on developing and commercializing novel vaccines, today reported financial ...

Kyverna reported $286.0M in cash, cash equivalents, and available-for-sale marketable securities as of December 31, 2024. The company expects ...

Meta Platforms' net cash and marketable securities position reached a record high to close out 2024. Read why I remain ...

Q4 2024 Earnings Call Transcript March 27, 2025 BioRestorative Therapies, Inc. beats earnings expectations. Reported EPS is $ ...

We recently published a list of 15 Cheapest Stocks Insiders Are Buying In March. In this article, we are going to take a look ...

Discover why high valuations, cash burn concerns, and weak financial reporting make this stock a strong sell despite ...

One beaten-down Magnificent Seven stock that's looking increasingly appealing is Alphabet. It's down about 20% from February's all-time high, but its business has a ton of momentum behind it. If ...

GameStop has updated its investment policy to allow the company to hold “certain cryptocurrency assets, including Bitcoin and ...

Inhibikase Therapeutics, Inc. (Nasdaq: IKT) (“Inhibikase” or “Company”), a clinical-stage pharmaceutical company innovating small molecule kinase inhibitor therapeutics to treat pulmonary arterial ...

Three stocks that are trading at attractive valuations right now that you may not want to overlook are Bristol Myers Squibb ( ...